{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:03:46Z","timestamp":1777806226285,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472217"],"award-info":[{"award-number":["81472217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4820-9","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T12:36:12Z","timestamp":1537274172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment"],"prefix":"10.1186","volume":"18","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia-Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Feng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Gang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"4820_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245\u201355.","journal-title":"Lancet"},{"key":"4820_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/SLA.0b013e31818eec29","volume":"249","author":"WY Lau","year":"2009","unstructured":"Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20\u20135.","journal-title":"Ann Surg"},{"key":"4820_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4292\/wjgpt.v7.i4.477","volume":"7","author":"A Facciorusso","year":"2016","unstructured":"Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: an updated review. World J Gastrointest Pharmacol Ther. 2016;7:477\u201389.","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"4820_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/SLA.0b013e31818eec29","volume":"249","author":"WY Lau","year":"2009","unstructured":"Lau WY, Lai ECH. The current role of radiofrequency ablation in the management of hepatocellular carcinoma. Ann Surg. 2009;249:20\u20135.","journal-title":"Ann Surg"},{"key":"4820_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12072-007-9040-3","volume":"2","author":"K Obara","year":"2008","unstructured":"Obara K, Matsumoto N, Okamoto M, Kobayashi M, Ikeda H, Takahashi H, et al. Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int. 2008;2:116\u201323.","journal-title":"Hepatol Int"},{"key":"4820_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-199907000-00001","volume":"230","author":"SA Curley","year":"1999","unstructured":"Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg. 1999;230:1\u20138.","journal-title":"Ann Surg"},{"key":"4820_CR7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","volume":"252","author":"J Huang","year":"2010","unstructured":"Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903\u201312.","journal-title":"Ann Surg"},{"key":"4820_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","volume":"57","author":"K Feng","year":"2012","unstructured":"Feng K, Yan J, Li X, Xia F, Ma K, Wang S, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57:794\u2013802.","journal-title":"J Hepatol"},{"key":"4820_CR9","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.26526","volume":"58","author":"S Yoshida","year":"2013","unstructured":"Yoshida S, Kornek M, Ikenaga N, Schmelzle M, Masuzaki R, Csizmadia E, et al. Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma. Hepatology. 2013;58:1667\u201380.","journal-title":"Hepatology"},{"key":"4820_CR10","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00270-013-0828-3","volume":"37","author":"SM Thompson","year":"2014","unstructured":"Thompson SM, Callstrom MR, Butters KA, Sutor SL, Knudsen B, Grande JP, et al. Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study. Cardiovasc Intervent Radiol. 2014;37:1343\u201351.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4820_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088913","volume":"9","author":"L Wu","year":"2014","unstructured":"Wu L, Fu Z, Zhou S, Gong J, Liu CA, Qiao Z, et al. HIF-1\u03b1 and HIF-2\u03b1: siblings in promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation. PLoS One. 2014;9:e88913.","journal-title":"PLoS One"},{"key":"4820_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395\u2013406.","journal-title":"J Cell Biol"},{"key":"4820_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009;139:891\u2013906.","journal-title":"Cell"},{"key":"4820_CR14","first-page":"6496","volume":"63","author":"TT Wissniowski","year":"2003","unstructured":"Wissniowski TT, H\u00e4nsler J, Neureiter D, Frieser M, Schaber S, Esslinger B, et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 2003;63:6496\u2013500.","journal-title":"Cancer Res"},{"key":"4820_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/gutjnl-2014-308286","volume":"65","author":"B Behm","year":"2016","unstructured":"Behm B, Di Fazio P, Michl P, Neureiter D, Kemmerling R, Hahn EG, et al. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation. Gut. 2016;65:134\u201343.","journal-title":"Gut"},{"key":"4820_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1540-8167.2006.00428.x","volume":"17","author":"P Kovoor","year":"2006","unstructured":"Kovoor P, Daly M, Mikhail M, Eipper V, Dewsnap B, Ross DL. Change in size of lesions over 3 weeks after radiofrequency ablation of left ventricle. J Cardiovasc Electrophysiol. 2006;17:411\u20134.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"4820_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.15141918","volume":"276","author":"N Rozenblum","year":"2015","unstructured":"Rozenblum N, Zeira E, Bulvik B, Gourevitch S, Yotvat H, Galun E, et al. Radiofrequency ablation: inflammatory changes in the Periablative zone can induce global organ effects, including liver regeneration. Radiology. 2015;276:416\u201325.","journal-title":"Radiology"},{"key":"4820_CR18","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1158\/1078-0432.CCR-03-0825","volume":"10","author":"T Armstrong","year":"2004","unstructured":"Armstrong T, Packham G, Murphy LB, Bateman AC, Conti JA, Fine DR, et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004;10:7427\u201337.","journal-title":"Clin Cancer Res"},{"key":"4820_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1165\/rcmb.2007-0071OC","volume":"38","author":"Y Shintani","year":"2008","unstructured":"Shintani Y, Maeda M, Chaika N, Keith RJ, Margaret JW. Collagen I promotes epithelial-to-mesenchymal transition in lung Cancer cells via transforming growth factor\u2013\u03b2 signaling. Am J Respir Cell Mol Biol. 2008;38:95\u2013104.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4820_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1741-7015-6-11","volume":"6","author":"PP Provenzano","year":"2008","unstructured":"Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008;6:11.","journal-title":"BMC Med"},{"key":"4820_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jprot.2013.10.020","volume":"94","author":"X Zou","year":"2013","unstructured":"Zou X, Feng B, Dong T, Yan G, Tan B, Shen H, et al. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis. J Proteome. 2013;94:473\u201385.","journal-title":"J Proteome"},{"key":"4820_CR22","first-page":"751","volume":"4","author":"MC Yang","year":"2014","unstructured":"Yang MC, Wang CJ, Liao PC, Yen CJ, Shan YS. Hepatic stellate cells secrete type I collagen to trigger epithelial mesenchymal transition of hepatoma cells. Am J Cancer Res. 2014;4:751\u201363.","journal-title":"Am J Cancer Res"},{"key":"4820_CR23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-2407-14-108","volume":"14","author":"M Hayashi","year":"2014","unstructured":"Hayashi M, Nomoto S, Hishida M, Inokawa Y, Kanda M, Okamura Y, et al. Identification of the collagen type 1 \u03b1 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma. BMC Cancer. 2014;14:108.","journal-title":"BMC Cancer"},{"key":"4820_CR24","doi-asserted-by":"publisher","first-page":"E2595","DOI":"10.1073\/pnas.1212834109","volume":"109","author":"KV Nguyen-Ngoc","year":"2012","unstructured":"Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, Hines WC, et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A. 2012;109:E2595\u2013604.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4820_CR25","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/s41598-017-01177-6","volume":"7","author":"R Zhang","year":"2017","unstructured":"Zhang R, Yao RR, Li JH, Dong G, Ma M, Zheng QD, et al. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Sci Rep. 2017;7:2164.","journal-title":"Sci Rep"},{"key":"4820_CR26","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1111\/cas.13322","volume":"108","author":"R Zhang","year":"2017","unstructured":"Zhang R, Ma M, Dong G, Yao RR, Li JH, Zheng QD, et al. Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment. Cancer Sci. 2017;108:1778\u201386.","journal-title":"Cancer Sci"},{"key":"4820_CR27","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23:1424\u201335.","journal-title":"Nat Med"},{"key":"4820_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13045-016-0253-6","volume":"9","author":"A You","year":"2016","unstructured":"You A, Cao M, Guo Z, Zuo B, Gao J, Zhou H, et al. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models. J Hematol Oncol. 2016;9:20.","journal-title":"J Hematol Oncol"},{"key":"4820_CR29","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras\/Raf\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12:3045\u201350.","journal-title":"Oncol Lett"},{"key":"4820_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.hepres.2004.02.009","volume":"29","author":"YH Hwang","year":"2004","unstructured":"Hwang YH, Choi JY, Kim S, Chung ES, Kim T, Koh SS, et al. Over-expression of c-Raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatol Res. 2004;29:113\u201321.","journal-title":"Hepatol Res"},{"key":"4820_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jhep.2007.08.018","volume":"48","author":"KJ Schmitz","year":"2007","unstructured":"Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, et al. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol. 2007;48:83\u201390.","journal-title":"J Hepatol"},{"key":"4820_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. SHARP investigators study group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"4820_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-012-0690-0","volume":"48","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, et al. Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol. 2013;48:951\u201365.","journal-title":"J Gastroenterol"},{"key":"4820_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/hepr.12705","volume":"47","author":"T Ikemoto","year":"2017","unstructured":"Ikemoto T, Shimada M, Yamada S. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. Hepatol Res. 2017;47:23\u201330.","journal-title":"Hepatol Res"},{"key":"4820_CR35","doi-asserted-by":"crossref","unstructured":"Scherber PR, G\u00e4belein G, Eisele RM, Igna D, Glanemann M. Early stage liver cancer: Hepatocellular carcinoma. Chirurg. 2018;89:281-8.","DOI":"10.1007\/s00104-017-0538-5"},{"key":"4820_CR36","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838\u201351.","journal-title":"Lancet"},{"key":"4820_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214:199\u2013210.","journal-title":"J Pathol"},{"key":"4820_CR38","first-page":"211","volume":"25","author":"J Liu","year":"2018","unstructured":"Liu J, Shen JX, Wu HT, Li XL, Wen XF, Du CW, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25:211\u201323.","journal-title":"Discov Med."},{"issue":"6","key":"4820_CR39","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/cas.13624","volume":"109","author":"Shota Yamazaki","year":"2018","unstructured":"Yamazaki S, Higuchi Y, Ishibashi M, Hashimoto H, Yasunaga M, Matsumura Y, et al. Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway. Cancer Sci. 2018;109:2063-73.","journal-title":"Cancer Science"},{"key":"4820_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.matbio.2017.11.002","volume":"66","author":"Olena Molokanova","year":"2018","unstructured":"Molokanova O, Sch\u00f6nig K, Weng SY, Wang X, Bros M, Diken M, et al. Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulatedmatrix genes and attenuated inflammation. Matrix Biol. 2018;66:34-49.","journal-title":"Matrix Biology"},{"key":"4820_CR41","doi-asserted-by":"crossref","first-page":"21650","DOI":"10.18632\/oncotarget.15521","volume":"8","author":"Y Song","year":"2017","unstructured":"Song Y, Kim JS, Choi EK, Kim J, Kim KM, Seo HR. TGF-\u03b2-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC. Oncotarget. 2017;8:21650\u201362.","journal-title":"Oncotarget"},{"key":"4820_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yexcr.2017.11.035","volume":"362","author":"Y Chen","year":"2018","unstructured":"Chen Y, Ou Y, Dong J, Yang G, Zeng Z, Liu Y, et al. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Exp Cell Res. 2018;362:343\u20138.","journal-title":"Exp Cell Res"},{"key":"4820_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling. Hepatology. 2012;55:594\u2013608.","journal-title":"Hepatology"},{"key":"4820_CR44","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1148\/radiol.2015141695","volume":"276","author":"N Rozenblum","year":"2015","unstructured":"Rozenblum N, Zeira E, Scaiewicz V, Bulvik B, Gourevitch S, Yotvat H, et al. Oncogenesis: an \u201coff-target\u201d effect of radiofrequency ablation. Radiology. 2015;276:426\u201332.","journal-title":"Radiology"},{"key":"4820_CR45","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2005.01.3441","volume":"24","author":"GK Abou-Alfa","year":"2006","unstructured":"Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24:4293\u2013300.","journal-title":"J Clin Oncol"},{"key":"4820_CR46","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/1078-0432.CCR-13-0547","volume":"20","author":"JM Llovet","year":"2014","unstructured":"Llovet JM, Hernandez-Gea V. Hepatocellular carcinoma: reasons for phase III failure and novel perspectives on trial design. Clin Cancer Res. 2014;20:2072\u20139.","journal-title":"Clin Cancer Res"},{"key":"4820_CR47","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jhep.2009.03.028","volume":"51","author":"P Newell","year":"2009","unstructured":"Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, et al. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol. 2009;51:725\u201333.","journal-title":"J Hepatol"},{"key":"4820_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1258\/ar.2012.120249","volume":"54","author":"M Xu","year":"2013","unstructured":"Xu M, Xie XH, Xie XY, Xu ZF, Liu GJ, Zheng YL, et al. Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: an experiment in vivo. Acta Radiol. 2013;54:199\u2013204.","journal-title":"Acta Radiol"},{"key":"4820_CR49","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s00330-016-4405-4","volume":"27","author":"G Kumar","year":"2017","unstructured":"Kumar G, Goldberg SN, Wang Y, Velez E, Gourevitch S, Galun E, et al. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. Eur Radiol. 2017;27:1238\u201347.","journal-title":"Eur Radiol"},{"issue":"7","key":"4820_CR50","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1080\/02656736.2018.1462535","volume":"34","author":"Muneeb Ahmed","year":"2018","unstructured":"Ahmed M, Kumar G, Gourevitch S, Levchenko T, Galun E, Torchilin V, et al. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins. Int J Hyperthermia. 2018;34:934-42.","journal-title":"International Journal of Hyperthermia"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4820-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4820-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T04:24:27Z","timestamp":1604982267000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4820-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4820"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4820-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were carried out in compliance with the guidelines by the Shanghai Medical Experimental Animal Care Commission. The experimental protocols were approved by the Ethical Committee on Animal Experiments of Fudan University, Shanghai China (Permit Number: 201807002Z).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"901"}}